QUESTION 1
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs to
manage the top-down cortical control and the
... [Show More] excessive drive from striatal hyperactivity?
A. Stimulants
B. Antidepressants
C. Antipsychotics
D. SSRIs
QUESTION 2
The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic
behaviors with poor impulse control and aggression. Of the available treatments, which can help
temper some of the adverse effects or symptoms that are normally caused by D2 antagonism?
A. First-generation, conventional antipsychotics
B. First-generation, atypical antipsychotics
C. Second-generation, conventional antipsychotics
D. Second-generation, atypical antipsychotics
QUESTION 3
The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive
behaviors in patients with the student. Why does the PMHNP prescribe a standard dose of
atypical antipsychotics?
A. The doses are based on achieving 100% D2 receptor occupancy.
B. The doses are based on achieving a minimum of 80% D2 receptor occupancy.
C. The doses are based on achieving 60% D2 receptor occupancy.
D. None of the above.
QUESTION 4
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?
A. There is too high a risk of serious adverse side effects.
B. It can exaggerate the psychotic symptoms.
C. Clozapine (Clozaril) should not be used as high-dose monotherapy.
D. There is no documentation that clozapine (Clozaril) is effective for patients who are violent.
QUESTION 5
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the
PMHNP exhibits proper care for this patient?
A. Explaining to the patient that there are no risks of EPS
B. Prescribing the patient 12 mg/dail
C. Titrating the dose by increasing it every 5–7 days
D. Writing a prescription for a higher dose of oral risperidone (Risperdal) to achieve high D2
receptor occupancy
QUESTION 6
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and
impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer will
the PMHNP select?
A. Lithium (Lithane)
B. Phenytoin (Dilantin)
C. Valproate (Depakote)
D. Topiramate (Topamax)
QUESTION 7
The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on
their child. The parents prefer to start pharmacological treatment with a non-stimulant. Which
medication will the PMHNP will most likely prescribe?
A. Strattera
B. Concerta
C. Daytrana
D. Adderall
QUESTION 8
The PMHNP understands that slow-dose extended release stimulants are most appropriate for
which patient with ADHD?
A. 8-year-old patient
B. 24-year-old patient
C. 55-year-old patient
D. 82-year-old patient
QUESTION 9
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the
PMHNP include when discussing the side effects with the patient?
A. The formulation can have delayed actions when taken with food.
B. Sedation can be a common side effect of the drug.
C. The medication can affect your blood pressure.
D. This drug does not cause any dependency.
QUESTION 10
The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will the
PMHNP include in the teaching?
A. The second dose should be taken at lunch.
B. There are no risks for insomnia.
C. There is only one daily dose, to be taken in the morning.
D. There will be continued effects into the evening.
QUESTION 11
A young patient is prescribed Vyvanse. During the follow-up appointment, which comment made
by the patient makes the PMHNP think that the dosing is being done incorrectly?
A. “I take my pill at breakfast.”
B. “I am unable to fall asleep at night.”
C. “I feel okay all day long.”
D. “I am not taking my pill at lunch.”
QUESTION 12
A 14-year-old patient is prescribed Strattera and asks when the medicine should be taken. What
does the PMHNP understand regarding the drug’s dosing profile?
A. The patient should take the medication at lunch.
B. The patient will have one or two doses aday.
C. The patient will take a pill every 17 hours.
D. The dosing should be done in the morning and at night.
QUESTION 13
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing practices
when she prescribes the following dose:
A. The child will be prescribed 2.5 mg.
B. The child will be prescribed a 10-mg tablet.
C. The child’s dose will increase by 2.5 mg every other week.
D. The child will take 10–40 mg, daily.
QUESTION 14
A patient is being prescribed bupropion and is concerned about the side effects. What will the
PMHNP tell the patient regarding bupropion?
A. Weight gain is not unusual.
B. Sedation may be common.
C. It can cause cardiac arrhythmias.
D. It may amplify fatigue.
QUESTION 15
Which patient will receive a lower dose of guanfacine?
A. Patient who has congestive heart failure
B. Patient who has cerebrovascular disease
C. Patientwho is pregnant
D. Patient with kidney disease
QUESTION 16
An 18-year-old female with a history of frequent headaches and a mood disorder is prescribed
topiramate (Topamax), 25 mg by mouth daily. The PMHNP understands that this medication is
effective in treating which condition(s) in this patient?
A. Migraines
B. Bipolar disorder and depression
C. Pregnancy-induced depression
D. Upper back pain
QUESTION 17
The PMHNP is treating a patient for fibromyalgia and is considering prescribing milnacipran
(Savella). When prescribing this medication, which action is the PMHNP likely to choose?
A. Monitor liver function every 6 months for a year and then yearly thereafter.
B. Monitor monthly weight.
C. Split the daily dose into two doses after the first day.
D. Monitor for occult blood in the stool.
QUESTION 18
The PMHNP is assessing a patient she has been treating with the diagnosis of chronic pain.
During the assessment, the patient states that he has recently been having trouble getting to sleep
and staying asleep. Based on this information, what action is the PMHNP most likely to take?
A. Order hydroxyzine (Vistaril), 50 mg PRN or as needed
B. Order zolpidem (Ambien), 5mg at bedtime
C. Order melatonin, 5mg at bedtime
D. Order quetiapine (Seroquel), 150 mg at bedtime
QUESTION 19
The PMHNP is assessing a female patient who has been taking lamotrigine (Lamictal) for
migraine prophylaxis. After discovering that the patient has reached the maximum dose of this
medication, the PMHNP decides to change the patient’s medication to zonisamide (Zonegran). In
addition to evaluating this patient’s day-to-day activities, what should the PMHNP ensure that [Show Less]